
Humacyte, Inc.
Humacyte, Inc. (HUMA)
WebsitePrice
Market cap
Next catalystExpected 2026CTEV — first-in-human Phase 2a CABG study · Data readoutCompany source ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved